1. Home
  2. PHAR vs ECX Comparison

PHAR vs ECX Comparison

Compare PHAR & ECX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHAR
  • ECX
  • Stock Information
  • Founded
  • PHAR 1988
  • ECX 2017
  • Country
  • PHAR Netherlands
  • ECX China
  • Employees
  • PHAR N/A
  • ECX N/A
  • Industry
  • PHAR Biotechnology: Pharmaceutical Preparations
  • ECX EDP Services
  • Sector
  • PHAR Health Care
  • ECX Technology
  • Exchange
  • PHAR Nasdaq
  • ECX Nasdaq
  • Market Cap
  • PHAR 627.5M
  • ECX 584.9M
  • IPO Year
  • PHAR N/A
  • ECX N/A
  • Fundamental
  • Price
  • PHAR $9.98
  • ECX $1.91
  • Analyst Decision
  • PHAR Strong Buy
  • ECX
  • Analyst Count
  • PHAR 3
  • ECX 0
  • Target Price
  • PHAR $27.00
  • ECX N/A
  • AVG Volume (30 Days)
  • PHAR 6.0K
  • ECX 1.6M
  • Earning Date
  • PHAR 03-13-2025
  • ECX 02-26-2025
  • Dividend Yield
  • PHAR N/A
  • ECX N/A
  • EPS Growth
  • PHAR N/A
  • ECX N/A
  • EPS
  • PHAR N/A
  • ECX N/A
  • Revenue
  • PHAR $285,745,000.00
  • ECX $778,608,168.00
  • Revenue This Year
  • PHAR $20.08
  • ECX $20.12
  • Revenue Next Year
  • PHAR $9.22
  • ECX $32.70
  • P/E Ratio
  • PHAR N/A
  • ECX N/A
  • Revenue Growth
  • PHAR 30.64
  • ECX 25.45
  • 52 Week Low
  • PHAR $6.65
  • ECX $0.96
  • 52 Week High
  • PHAR $13.20
  • ECX $3.09
  • Technical
  • Relative Strength Index (RSI)
  • PHAR 56.13
  • ECX 47.06
  • Support Level
  • PHAR $9.37
  • ECX $1.78
  • Resistance Level
  • PHAR $10.15
  • ECX $2.25
  • Average True Range (ATR)
  • PHAR 0.50
  • ECX 0.14
  • MACD
  • PHAR -0.09
  • ECX -0.02
  • Stochastic Oscillator
  • PHAR 57.53
  • ECX 27.35

About PHAR Pharming Group N.V.

Pharming Group is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. It is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines to serve the unserved rare disease patients. Its product includes Ruconest. The revenue is generated from the United States.

About ECX ECARX Holdings Inc. Ordinary shares

ECARX Holdings Inc is engaged in the sales of system-on-chip core modules, automotive computing platform products, and software stacks as well as the provision of research and development services primarily in the People's Republic of China. The company's core products include infotainment head units, digital cockpits, vehicle chip-set solutions, a core operating system, and an integrated software stack. Beyond this, ECARX is developing a full-stack automotive computing platform. It is engaged in automotive intelligence and networking.

Share on Social Networks: